Wegovy vs Mounjaro: Private Prescription Comparison Guide
Understanding What 1mg Wegovy Compares to in Mounjaro Dosing
When evaluating what 1mg of Wegovy is equivalent to Mounjaro, it's essential to understand these are fundamentally different medications that cannot be directly compared dose-for-dose. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors simultaneously. The 1mg Wegovy dose represents weeks 9-12 of your treatment escalation, typically when patients begin experiencing more pronounced appetite regulation effects.
Private prescription access in the UK allows patients to compare both options without the typical 6+ month NHS specialist referral waiting periods. Through EverydayMeds' streamlined service, you can access clinical consultation for either medication within 24 hours, rather than waiting for GP referral to specialist weight management services. This private route provides the same genuine Novo Nordisk Wegovy and Eli Lilly Mounjaro as NHS prescriptions, but with significantly faster access and personalised clinical guidance.
Private Prescription Pricing for Wegovy 1mg vs Mounjaro Equivalents
Wegovy 1mg costs £99.99 through our private prescription service, representing excellent value for weeks 9-12 of treatment when appetite suppression typically becomes well-established. Our Advance Duo bundle pairs 1mg with 1.7mg Wegovy for £269.99, providing seamless progression to higher doses. New customers can apply code FIRST40 at checkout, while returning patients benefit from code DOSE25, with these final prices reflecting post-discount costs.
Mounjaro pricing follows a different structure due to its unique dual-agonist mechanism, with equivalent stages priced competitively for private prescription patients. Both medications require prescription-only medicine oversight through our GPhC-registered pharmacy (#9012878), ensuring clinical safety standards match NHS provision. Private prescription eliminates the uncertainty of NHS availability while providing transparent, upfront pricing for your entire treatment journey.
Clinical Evidence: How 1mg Wegovy Compares to Mounjaro in Research
The STEP clinical trials demonstrated that patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes, with Wilding et al., NEJM, 2021 showing meaningful results emerging around the 1mg dose stage. However, direct comparison to Mounjaro's equivalent effectiveness isn't appropriate due to different trial designs, patient populations, and study endpoints.
Both medications have demonstrated cardiovascular benefits in their respective clinical programmes, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. This clinical evidence supports private prescription access for patients who meet eligibility criteria, providing confidence in treatment selection whether choosing Wegovy or Mounjaro through professional clinical assessment.
How Wegovy 1mg Works Compared to Mounjaro's Mechanism
Wegovy's semaglutide acts as a GLP-1 receptor agonist, mimicking your body's natural incretin hormones that signal fullness after eating. At the 1mg dose level, most patients experience established appetite reduction and enhanced satiety signals, helping create the caloric deficit necessary for weight management. The medication works primarily on brain appetite centres, reducing food cravings and promoting satisfaction with smaller portion sizes. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy focuses specifically on GLP-1 pathways, providing targeted appetite regulation. This mechanism must work alongside a reduced-calorie diet and increased physical activity for optimal effectiveness, as licensed by the MHRA.
Ordering Process: Private Wegovy vs Mounjaro Comparison
Our private prescription process takes just 3 minutes to complete the clinical assessment, covering eligibility criteria for both Wegovy and Mounjaro options. Following assessment submission, our prescribers review your case within standard 3 working days (or 24 hours with express service), determining which medication best suits your clinical profile. Once approved, both Wegovy 1mg and Mounjaro equivalents ship via next-day cold-chain delivery, maintaining temperature integrity throughout transport. This streamlined approach eliminates GP referral requirements and specialist waiting lists that typically delay NHS access. The entire process from assessment to delivery typically completes within one week, compared to months through traditional NHS routes.
Storage and Practical Differences: Wegovy vs Mounjaro
Wegovy offers a significant practical advantage with 6 weeks room temperature stability once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require initial refrigeration between 2-8°C, but Wegovy's extended room temperature tolerance makes travel and daily use more convenient. The 1mg Wegovy comes in Novo Nordisk's FlexTouch pen system, designed for once-weekly injection with pre-set dosing accuracy. Dose escalation from 1mg to 1.7mg must follow the licensed schedule, as skipping doses isn't recommended for safety and tolerability reasons. This practical flexibility often influences patient choice between the two options during private prescription consultations.
Why Private Prescription Makes Sense for Wegovy 1mg vs Mounjaro Decisions
Private prescription access allows real-time comparison between what 1mg Wegovy offers versus Mounjaro's equivalent stages, without NHS formulary restrictions or regional availability issues. Many patients find the private route essential when specific medication preference emerges from research or previous experience, as NHS services may only offer one option. The ability to switch between Wegovy and Mounjaro based on tolerance and effectiveness provides treatment flexibility rarely available through NHS channels.
Cost transparency in private prescription also enables informed decision-making about long-term treatment investment, with bundled options like our Advance Duo providing treatment continuity planning. This approach particularly benefits patients whose BMI or comorbidity profile meets private prescription criteria but falls outside current NHS commissioning guidelines for immediate access.
Expert Clinical Support for Treatment Selection
Our clinical team at EverydayMeds provides personalised guidance when comparing what 1mg Wegovy offers against Mounjaro equivalents, considering your individual medical history, lifestyle factors, and treatment goals. This expert consultation, included in your private prescription service, ensures appropriate medication selection based on clinical evidence rather than general population data. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy (#9012878), with clinical oversight maintaining the same safety standards as NHS provision. Book your consultation today at https://everydaymeds.co.uk/products/wegovy-1mg to access expert comparison guidance and begin treatment without NHS delays. Use code FIRST40 for new customers or DOSE25 for returning patients, with next-day delivery ensuring rapid treatment initiation once clinically approved.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
